9 results
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... /dc17-2231 #Metformin ... #CKD4 #Dosing #Pharmacology
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
Metformin - oral ... antihyperglycemic agent for treatement ... of type II diabetes ... #Pharmacology #Metformin
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Metformin - First ... Line Treatment ... for Diabetes Type ... Indications #Titration #Pharmacology ... #Diabetes #DM2
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
initiation of treatment ... FDA recommends, metformin ... should NOT be used ... and CKD should ... evidence-based pharmacologic
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... pregabalin as treatment ... #Pharmacology #
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... risks, and therapy should ... #pharmacology #pharmacotherapy ... endocrinology #treatment
Metformin: Biguanide
Metformin is the first-line medication for treatment of type 2 diabetes. It is very effective
Metformin is the ... medication for treatment ... of type 2 diabetes ... #Pharmacology # ... Mechanism #Diabetes
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
What we should be ... perfusion - shock->treatments ... before beginning treatment ... • Type B1: - Diabetes ... and Toxins: - Metformin
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology #